Surgery Partners Decides to Remain Independent

Surgery Partners ( (SGRY) ) has provided an update.

On June 17, 2025, Surgery Partners, Inc. announced that its Special Committee of independent directors, after discussions with Bain Capital regarding a proposal to acquire all outstanding shares not owned by Bain, decided to continue as an independent publicly traded company. The decision reflects the Committee’s confidence in Surgery Partners’ long-term growth prospects and ability to enhance shareholder value through its established growth algorithm and business execution. The company reaffirmed its financial guidance for 2025 and plans to host an Investor Day in the second half of the year to discuss future growth plans and industry trends.

The most recent analyst rating on (SGRY) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Surgery Partners stock, see the SGRY Stock Forecast page.

Spark’s Take on SGRY Stock

According to Spark, TipRanks’ AI Analyst, SGRY is a Neutral.

Surgery Partners scores 63, driven by strong cash flow generation and positive growth signals from the earnings call. However, high financial leverage, ongoing net losses, and valuation challenges weigh on the score. Strong revenue and case growth, alongside successful physician recruitment, bolster the company’s outlook despite margin pressure and interest rate challenges.

To see Spark’s full report on SGRY stock, click here.

More about Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care. Founded in 2004, it operates more than 200 locations across 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities.

Average Trading Volume: 998,628

Technical Sentiment Signal: Sell

Current Market Cap: $2.97B

See more data about SGRY stock on TipRanks’ Stock Analysis page.